World Pancreatic Cancer Day just passed, reminding us of the urgent need to support individuals and families affected by this challenging disease. We are proud to partner with Let’s Win Pancreatic Cancer to launch its innovative global Clinical Trial Finder. This AI-powered tool enhances access to critical clinical trial information, providing personalized results based on a user’s location and health history. With precise AI-guided searches and bilingual navigators offering support in English and Spanish, the Trial Finder is designed to make clinical trial participation more accessible and inclusive for the global pancreatic cancer community. Let’s Win Pancreatic Cancer continues to be a trusted resource for patients and caregivers, offering vital tools and information for navigating their journey. Read More.
What’s New at TrialX! 🚀
PRODUCT UPDATES
🪞 DRIVING DIVERSITY IN CLINICAL TRIAL PARTICIPATION THROUGH ART
We’re grateful to be part of a journey shaping a more inclusive future! We are honored to power the clinical trial finder for the landmark Reflections initiative, which enhances diversity in clinical trials and increases awareness at the grassroots level through artistic expression. We had an incredible experience at the #ReflectionsAtlanta event in Downtown Atlanta last month, connecting with potential participants and simplifying their path to clinical trials using our trial finder and advanced AI tools. This initiative, driving visitors to BeReflected.org, provides valuable resources to support individuals on their journey to trial participation. Read more. 🍂
🤳 REMOTE DATA COLLECTION FOR A LEADING CLINICAL RESEARCH STUDY
Leveraging TrialX’s remote data collection solutions researchers at the University of Iowa have developed the SAYSTOP study app to explore a critical question: Is it safe for patients with urinary tract infections to stop antibiotics when they feel better, rather than completing the full course? This intuitive mobile app empowers participants to track and manage their antibiotic use seamlessly, providing valuable insights for the study. With antibiotic resistance posing a serious global health threat due to overuse and misuse, this research aims to inform safer, more effective antibiotic practices. Learn more.
🏥REDUCING SITE BURDEN
Clinical research sites, from academic centers to private practices, face numerous challenges in conducting trials. As a leader in clinical trial innovation, we’re committed to streamlining processes and boosting efficiency. Here we explore strategies to ease site burden and share how TrialX solutions are driving more effective, outcome-focused research. Read more.
RECENT CURETALKS 
Listen to Dr. Courtney Schreiber of Penn Medicine discuss management of Rh sensitization in pregnancy & talk about her research which has the potential to change pregnancy care guidelines & bridge global health equity gaps. The presence or absence of the Rh antigen on human red blood cells determines if a person’s blood type is “positive” or “negative.” When an Rh-negative individual, who lacks this antigen, becomes pregnant and carries an Rh-positive fetus, the mother’s immune system may recognize the fetus’s Rh antigen as foreign and mount an immune response. Watch here.
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
SERENE Study: Researchers at Penn Medicine are looking for participants aged 18-100 years to explore how a coping skills program can help patients with Chronic Obstructive Pulmonary Disease (COPD) and their support persons manage emotional distress.
Adults With or Without Chronic Kidney Disease Needed for CBD Study: Have you ever wondered about the safety of medicinal CBD? Researchers at Indiana University are investigating the safety of CBD with tacrolimus, an agent taken by transplant patients to prevent organ rejection. They are also seeking to understand the interaction between CBD and tacrolimus along with the underlying genetic factor.
Resilient Together for Dementia (RT-D) : Researchers at Icahn School of Medicine at Mount Sinai are exploring the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention aimed at preventing chronic emotional distress and preserving quality of life among at risk couples, early after a diagnosis of Alzheimer’s disease or a related dementia.
Have Eczema or Atopic Dermatitis? You could help discover the next generation of targeted, steroid-free potential medicines. This 10 month long study is exploring if two potential medicines can safely and effectively reduce signs and symptoms of moderate to severe eczema.
🌎 AROUND THE WEB
🛸 The smelly space mystery.
🐙 Like squids in the ocean – A bioinspired capsule pumps drugs directly into GI Tract wall.
👩 Taboo to treatment: By 2030 ~47m women worldwide will enter menopause each year.
‼️ NOTEWORTHY
🤝 TEAM UPDATES
🦃 HAPPY THANKSGIVING 🎉
“Feeling gratitude and not expressing it is like wrapping a present and not giving it.” – said William Arthur Ward, a motivational writer and educator. This Thanksgiving, we reflect on 16 incredible years since bringing TrialX to life as the first app to match individuals with clinical trials using personal health data from Google Health and Microsoft HealthVault. It has been a thrilling journey filled with groundbreaking innovations, milestones, and invaluable lessons. We’re deeply grateful to our clients, partners, and employees who have supported us every step of the way, helping us advance clinical trial technologies both on Earth and beyond. Here’s to a joyful Thanksgiving season filled with gratitude and endless possibilities ahead! 🦃🍂
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the moon!
All the best,
Team TrialX
